Os07g0114000 Antibody

What is Os07g0114000 and why is it significant in rice research?

Os07g0114000 encodes a probable protein phosphatase 2C 61 (OsPP2C61) with enzymatic activity classified as EC 3.1.3.16. This 377-amino acid protein plays critical roles in rice signaling pathways . The significance of this protein stems from its involvement in protein dephosphorylation mechanisms that regulate cellular processes in Oryza sativa. Research on this protein has implications for understanding stress responses, growth regulation, and developmental processes in rice. The protein's evolutionary conservation makes it a valuable target for comparative studies across plant species.

What types of Os07g0114000 antibodies are currently available for research applications?

Current research tools include region-specific monoclonal antibodies targeting different domains of the OsPP2C61 protein. Available antibodies include:

These combination antibodies each contain multiple individual monoclonal antibodies targeting specific epitopes within the designated region . This design enhances detection capabilities while allowing subsequent deconvolution for epitope-specific applications.

How should researchers validate Os07g0114000 antibody specificity before experimental applications?

Antibody validation requires a multi-pronged approach to ensure specificity for Os07g0114000-encoded protein. An effective validation protocol includes:

• Comparative Western blotting using wild-type and Os07g0114000 knockout/knockdown rice tissues to verify signal absence in genetic nulls

• Competitive binding assays with purified recombinant protein or immunizing peptides

• Immunoprecipitation followed by mass spectrometry to confirm target identity

• Cross-reactivity assessment against closely related PP2C family members using heterologous expression systems

What are the optimal conditions for using Os07g0114000 antibodies in immunoblotting experiments?

Optimal western blotting conditions for Os07g0114000 antibodies require careful optimization:

• Sample preparation: Extraction in phosphatase-inhibitor supplemented buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, 5mM EDTA) with protease inhibitors

• Protein loading: 20-50μg total protein per lane, with recombinant OsPP2C61 as positive control

• Transfer conditions: Semi-dry transfer at 15V for 45 minutes using PVDF membrane

• Blocking: 5% non-fat dry milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature

• Primary antibody: Dilute X-Q7XHN8 antibodies 1:1000 in 2% BSA/TBST, incubate overnight at 4°C

• Detection: HRP-conjugated anti-mouse secondary antibody (1:5000) with ECL detection

Researchers should conduct preliminary titration experiments to determine optimal antibody concentrations for their specific tissue samples, as protein abundance varies with developmental stage and environmental conditions. Drawing from antibody application principles established in other systems, these protocols can be adapted to rice-specific research requirements .

How can Os07g0114000 antibodies be effectively utilized in immunoprecipitation studies?

For successful immunoprecipitation with Os07g0114000 antibodies:

• Prepare fresh tissue lysate in non-denaturing buffer (50mM HEPES pH 7.4, 150mM NaCl, 0.5% NP-40) with protease and phosphatase inhibitors

• Pre-clear lysate with protein G beads (50μL slurry per 1mg protein) for 1 hour at 4°C

• Incubate pre-cleared lysate with 5-10μg antibody overnight at 4°C with gentle rotation

• Add 50μL protein G beads, incubate 3 hours at 4°C

• Wash 4× with IP buffer containing decreasing detergent concentrations

• Elute in 2× Laemmli sample buffer or low-pH glycine buffer depending on downstream applications

For co-immunoprecipitation studies, modify washing stringency to preserve protein-protein interactions. When investigating transient interactions, consider crosslinking approaches using DSP or formaldehyde before cell lysis. Similar methodological approaches have been successfully employed for other plant protein phosphatases and can be adapted for OsPP2C61 research .

What controls are essential when using Os07g0114000 antibodies in immunolocalization experiments?

Immunolocalization requires rigorous controls to ensure reliable subcellular localization data:

• Primary antibody specificity controls:

  • Preabsorption with immunizing peptide/recombinant protein

  • Parallel staining with pre-immune serum

  • Staining in Os07g0114000 knockout/knockdown tissues

• Technical controls:

  • Secondary antibody-only control to detect non-specific binding

  • Autofluorescence assessment in unstained samples

  • Co-staining with established subcellular markers

• Validation approaches:

  • Comparison with OsPP2C61-GFP fusion protein localization

  • Correlation with in silico prediction of subcellular targeting

  • Independent confirmation using subcellular fractionation

Researchers should document tissue fixation conditions in detail, as overfixation can mask epitopes and underfixation can alter subcellular architecture. These approaches align with best practices established for antibody-based localization studies while addressing plant-specific challenges .

How can cryoEM techniques be adapted for structural analysis of Os07g0114000 antibody-antigen complexes?

Adapting cryoEM for Os07g0114000 antibody-antigen structural analysis requires:

• Sample preparation optimization:

  • Express and purify recombinant OsPP2C61 to >95% purity

  • Form antibody-antigen complexes at 3:1 molar ratio

  • Screen buffer conditions (pH 6.5-8.0, salt 50-200mM) to identify stable complexes

  • Apply 3-4μL to glow-discharged grids followed by blotting and vitrification

• Data collection parameters:

  • Use 300kV transmission electron microscope

  • Collect 2,000-5,000 movies at 0.5-1.0 e-/Ų/frame

  • Target 1.5-2.5Å/pixel sampling

• Image processing workflow:

  • Motion correction with MotionCor2

  • CTF estimation with CTFFIND4

  • Particle picking using reference-free approaches

  • 2D classification to eliminate damaged particles

  • Ab initio model building followed by 3D refinement

The resulting structures can reveal epitope-paratope interactions at near-atomic resolution. This approach parallels methods used successfully for antibody characterization in other systems, where polyclonal antibody families have been identified through structural analysis . Resolution of 3-4Å is typically achievable with well-behaved samples.

What strategies can address data inconsistencies when different Os07g0114000 antibodies yield contradictory results?

When facing contradictory results with different Os07g0114000 antibodies:

• Systematic epitope mapping to determine precise binding sites:

  • Generate overlapping peptide arrays covering the full OsPP2C61 sequence

  • Test all antibodies against the array to identify exact epitope recognition patterns

  • Correlate epitope accessibility with protein conformation states

• Validation through orthogonal methods:

  • Compare antibody results with transcript quantification (RT-qPCR)

  • Employ CRISPR/Cas9-mediated epitope tagging at the endogenous locus

  • Use mass spectrometry-based protein quantification as reference

• Parameter-controlled comparative analysis:

  • Standardize sample preparation across all antibody tests

  • Develop an integrated scoring system incorporating multiple antibody results

  • Weight evidence based on validated antibody performance metrics

This multi-faceted approach can reconcile divergent results by identifying context-dependent factors affecting epitope accessibility. Similar strategies have proven effective in resolving contradictions in antibody-based studies of complex antigens .

How can researchers apply Os07g0114000 antibodies to study protein-protein interaction networks?

For comprehensive protein interaction network analysis:

• Proximity-dependent labeling approaches:

  • Generate OsPP2C61-BioID or OsPP2C61-APEX2 fusion constructs

  • Express in rice protoplasts or stable transgenic plants

  • Induce biotinylation of proximal proteins

  • Purify biotinylated proteins using streptavidin

  • Identify interaction partners via mass spectrometry

  • Validate specific interactions using Os07g0114000 antibodies in co-IP experiments

• In situ interaction mapping:

  • Apply proximity ligation assay (PLA) with Os07g0114000 antibodies and antibodies against suspected interaction partners

  • Quantify PLA signals across different tissues and conditions

  • Correlate interaction patterns with physiological responses

• Dynamic interaction analysis:

  • Use fluorescently-labeled Os07g0114000 antibody fragments (Fabs) for live-cell imaging

  • Measure interaction kinetics through fluorescence recovery after photobleaching (FRAP)

  • Apply fluorescence resonance energy transfer (FRET) with labeled antibodies to detect nanoscale proximity

These methodologies can reveal both stable and transient interactions, providing insights into OsPP2C61's role in signaling networks. The strategy incorporates both traditional and emerging techniques to build comprehensive interaction maps .

How can single-cell approaches be combined with Os07g0114000 antibodies for tissue-specific expression analysis?

Integrating single-cell techniques with Os07g0114000 antibodies enables unprecedented spatial resolution:

• Single-cell protein profiling workflow:

  • Prepare plant protoplasts under conditions preserving native protein states

  • Perform intracellular antibody staining with fluorescently-labeled Os07g0114000 antibodies

  • Analyze using flow cytometry or imaging flow cytometry

  • Correlate protein expression with cell-type specific markers

• Spatial transcriptomics integration:

  • Perform immunohistochemistry with Os07g0114000 antibodies on tissue sections

  • Apply spatial transcriptomics protocols on adjacent sections

  • Develop computational pipelines to correlate protein localization with transcript distribution

  • Generate spatially-resolved protein-RNA correlation maps

• Mass cytometry adaptation:

  • Conjugate Os07g0114000 antibodies with rare earth metals

  • Analyze single-cell protein expression in conjunction with multiple cellular markers

  • Cluster cell populations based on protein expression profiles

  • Identify cell state transitions associated with OsPP2C61 expression changes

These approaches provide unprecedented insights into cell-type specific functions of OsPP2C61, revealing heterogeneity masked in bulk tissue analyses. This strategy adapts emerging single-cell technologies from mammalian systems to plant research applications .

What computational approaches can enhance Os07g0114000 antibody epitope prediction and characterization?

Advanced computational methods for epitope analysis include:

• Integrated structural prediction pipeline:

  • Generate AlphaFold2 prediction of OsPP2C61 structure

  • Perform molecular dynamics simulations to sample conformational states

  • Apply BepiPred-3.0 and other epitope prediction algorithms

  • Calculate surface accessibility and electrostatic properties

  • Identify candidate epitopes for antibody recognition

• Machine learning-enhanced epitope mapping:

  • Train random forest or deep learning models using experimentally validated epitopes

  • Extract sequence and structural features from OsPP2C61

  • Predict epitope regions with associated confidence scores

  • Validate predictions through targeted mutagenesis and binding assays

• Antibody-antigen docking simulation:

  • Model antibody variable domains based on sequence information

  • Perform molecular docking simulations with predicted OsPP2C61 structure

  • Evaluate binding energy landscapes and interaction interfaces

  • Design experiments to test computational predictions

These in silico approaches can guide experimental design and interpretation, reducing resource requirements for comprehensive epitope characterization. Similar computational pipelines have successfully guided antibody research in other systems .

How can researchers overcome background issues when using Os07g0114000 antibodies in rice tissues?

To minimize background signal in immunodetection experiments:

• Optimization strategy for Western blotting:

  • Increase blocking stringency (5% BSA, 0.5% casein, or commercial blocking reagents)

  • Add 0.1-0.3% SDS to antibody dilution buffer to reduce hydrophobic interactions

  • Include 0.1% Tween-20 and 500mM NaCl in washing buffers

  • Perform sequential antibody dilution in rice knockout tissue lysate to absorb cross-reactive antibodies

  • Use highly pure recombinant OsPP2C61 for competitive blocking

• Immunohistochemistry background reduction:

  • Pretreat sections with hydrogen peroxide to block endogenous peroxidases

  • Include avidin/biotin blocking steps for biotin-based detection systems

  • Apply Sudan Black B (0.1% in 70% ethanol) to reduce autofluorescence

  • Use specific secondary antibodies tested for minimal cross-reactivity with plant proteins

  • Implement rigorous subtraction of tissue autofluorescence using spectral unmixing

These optimization steps often need to be empirically determined for each tissue type and developmental stage. The approaches build on established troubleshooting strategies while addressing plant-specific challenges .

What strategies can overcome limitations in Os07g0114000 antibody sensitivity for detecting low-abundance proteins?

For enhanced sensitivity in detecting low-abundance OsPP2C61:

• Signal amplification systems:

  • Tyramide signal amplification (TSA) providing 10-50× signal enhancement

  • Polymer-HRP conjugated secondary antibodies for increased sensitivity

  • Quantum dot-conjugated antibodies for improved signal-to-noise ratio

  • Sequential multiple antibody labeling to build detection complexes

• Sample preparation enhancements:

  • Subcellular fractionation to concentrate target protein

  • Immunoprecipitation before Western blotting (IP-Western)

  • Phosphatase inhibitor optimization to preserve phosphorylated forms

  • Proteasome inhibitor treatment to prevent protein degradation

• Detection system optimization:

  • Chemiluminescent substrates with extended signal duration

  • Direct fluorescent labeling of primary antibodies to eliminate secondary antibody background

  • Automated image acquisition with extended exposure integration

  • Computational image enhancement and background subtraction

These approaches can push detection limits to the sub-nanogram range, enabling visualization of low-abundance regulatory proteins like OsPP2C61. The strategy incorporates principles from studies detecting rare antibody populations in complex samples .